# OnCo record nct06613009 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06613009/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06613009", "NCT06613009" ;
  schema:name "Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer"@en ;
  schema:description "A phase 1 trial of IBI3009 in unresectable, metastatic or extensive-stage small-cell lung cancer, run by Innovent Biologics (Suzhou) Co. Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06613009/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06613009> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  schema:startDate "2024-12-30" ;
  onco:cancers <https://onco.cc/cancers/sclc/> ;
  onco:drugs <https://onco.cc/drugs/ibi3009/> ;
  onco:companies <https://onco.cc/companies/innovent/> .